News for hackers. Stuff that matters.
Re:About that Hydroxychloroquine for Covid-19 trial by ekianjo on Monday March 23, 2020 @06:35AM (#22662642)
> I don't see how doing poorly performed studys that tell us nothing is of any help.

Erm, even poorly designed studies tell you if there's any efficacy to expect or not. And it leads to better studies afterwards.

Science is iterative.

Re:About that Hydroxychloroquine for Covid-19 trial by hannob on Monday March 23, 2020 @06:40AM (#22662681)
What do you think this study tells us?

The way the authors have analyzed their data it tells us this is a promising drug. Had they done an intention to treat analysis very likely the opposite would've been the result.

The only thing that trial tells us is that if you do a bad trial you're as clueless as before.

Re:About that Hydroxychloroquine for Covid-19 trial by _ph_ on Monday March 23, 2020 @06:50AM (#22662735)
I am not a doctor, just a physicist, so I know about experimental data, but of course not about this study in detail. But as several sources dealing with this study confirm, it doesn't really tell us anything. So really at best it can be seen as reason to conduct a proper study, but the data itself does not yield any conclusion.
Re:About that Hydroxychloroquine for Covid-19 trial by ekianjo on Monday March 23, 2020 @07:02AM (#22662813)
There's a lot in medicine that goes into publication that has results not even borderline as meaningful as this. I would be careful to label this as "it doesn't really tell us anything". Especially since another study in China reached a similar conclusion.
Re:About that Hydroxychloroquine for Covid-19 trial by davrosthedalek on Monday March 23, 2020 @10:15AM (#22664282)
a) The quality, or lack of quality, of other studies does not affect the quality of the discussed study. b) The availability of another study with similar results, does not affect the quality of this study.
Re:About that Hydroxychloroquine for Covid-19 trial by zeckalpha on Monday March 23, 2020 @08:34AM (#22663418)
Poorly designed studies can lead to expensive and unnecessary followup studies.